Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EGF Antikörper (Biotin)

Der Ziege Polyklonal Anti-EGF-Antikörper wurde für EIA validiert. Er ist geeignet, EGF in Proben von Maus zu detektieren.
Produktnummer ABIN116363

Kurzübersicht für EGF Antikörper (Biotin) (ABIN116363)

Target

Alle EGF Antikörper anzeigen
EGF (Epidermal Growth Factor (EGF))

Reaktivität

  • 164
  • 90
  • 59
  • 18
  • 15
  • 8
  • 5
  • 1
  • 1
Maus

Wirt

  • 233
  • 54
  • 9
  • 2
  • 2
  • 1
Ziege

Klonalität

  • 234
  • 66
Polyklonal

Konjugat

  • 157
  • 35
  • 21
  • 13
  • 8
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser EGF Antikörper ist konjugiert mit Biotin

Applikation

  • 239
  • 110
  • 86
  • 70
  • 59
  • 53
  • 53
  • 27
  • 27
  • 17
  • 15
  • 12
  • 10
  • 8
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Enzyme Immunoassay (EIA)
  • Aufreinigung

    Affinity chromatography

    Immunogen

    Highly pure (>98%) recombinant mEGF.
  • Applikationshinweise

    ELISA: (Direct): To detect mEGF by direct ELISA (using 100 μL/well antibody solution) aconcentration of 0.25-1.0 μg/mL of this antibody is required. This biotinylated polyclonalantibody, in conjunction with compatible secondary reagents, allows the detection of atleast 0.2-0.4 ng/well of recombinant mEGF. (Sandwich): To detect mEGF by sandwich ELISA (using 100 μL/well antibody solution) aconcentration of 0.25-1.0 μg/mL of this antibody is required. This biotinylated polyclonalantibody, in conjunction with Polyclonal Anti-Murine EGF (PP1126P) as a capture antibody,allows the detection of at least 0.2-0.4 ng/well of recombinant mEGF. Western Blot: To detect mEGF by Western Blot analysis this antibody can be used at aconcentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagentsthe detection limit for recombinant mEGF is 1.5-3.0 ng/lane, under either reducing ornon-reducing conditions.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    Restore in sterile PBS containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2 without preservatives.

    Konservierungsmittel

    Without preservative

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
  • Target

    EGF (Epidermal Growth Factor (EGF))

    Andere Bezeichnung

    EGF

    Hintergrund

    Epidermal growth factor (EGF) has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells. The EGF precursor is believed to exist as a membrane bound molecule which is proteolytically cleaved to generate the 53 amino acid peptide hormone that stimulates cells to divide. EGF exerts its actions by binding to the EGFR, a 170 kDa protein. Epidermal growth factor (EGF) is a key growth factor regulating cell survival. Through its binding to cell surface receptors, EGF activates an extensive network of signal transduction pathways that include activation of the PI3K/AKT, RAS/ERK and JAK/STAT pathways. Because of its key role in driving the proliferation of cells, EGFR is a target of several anti-cancer drugs currently in development.Synonyms: Epidermal growth factor, HOMG4, Pro-epidermal growth factor, URG, Urogastrone

    Gen-ID

    10090

    UniProt

    P01132

    Pathways

    NF-kappaB Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Sie sind hier:
Chat with us!